Skip to main content
Trades ▾
Trading Strategies
Market Analysis
News
Tactics ▾
Fundamental
Options
Volatility
Dividends
Spin-Offs
COT
Education
Data ▾
Market Data
Interactive Charts
Sectors ▾
Commodities
Forex
Interest Rates
Energy
Crypto
Agriculture
Index
Equities
ETFs
FINtech
Alternative Data
Hedge Funds
Magazine ▾
Most Popular
Trader Questions
Trader Lists
Magazine Archives
About
Subscribe
Log in
Facebook
Twitter
Linkedin
Moderntrader
Mobile User menu
Subscribe
Log in
Main menu
Trades ▾
Trading Strategies
Market Analysis
News
Tactics ▾
Fundamental
Options
Volatility
Dividends
Spin-Offs
COT
Education
Data ▾
Market Data
Interactive Charts
Sectors ▾
Commodities
Forex
Interest Rates
Energy
Crypto
Agriculture
Index
Equities
ETFs
FINtech
Alternative Data
Hedge Funds
Magazine ▾
Most Popular
Trader Questions
Trader Lists
Magazine Archives
About
User menu
Subscribe
Log in
Search form
Search
Search
Ginger Gibson and David Shepardson, Reuters
Trump's genial private meetings with CEOs jar with public attacks
Ginger Gibson and David Shepardson, Reuters
March 8, 2017
When the bosses of some of the world's largest pharmaceutical companies headed to Washington in January to meet U.S. President Donald Trump, it had all the makings of a potentially hostile meeting.
